ED Coding & Reimbursement Alert - 2011 Issue 41
Part B Coding Coach: 4 Tips Help OB-Gyn Practices Prepare for CPT 2012 Adjustments
Subscribe or sign in to view the full article.
Article Overview
This article reviews a small set of CPT 2012 updates that may affect OB-Gyn practices, including procedure code changes, newly added service codes, and molecular pathology tests that physicians may order but not necessarily report themselves. It also notes associated diagnosis code changes for selected scenarios and highlights where CPT guidance, parenthetical references, and related reporting considerations matter for OB-Gyn and gyn oncology claims.
Why This Topic Matters
OB-Gyn coders and billing staff need to know which procedure and pathology updates may appear on claims, how related diagnosis coding changes are handled, and which services require attention to CPT notes and reporting relationships.
Article Sections
-
Prepare to Alter How You Report Implanon Insertions
Discusses a CPT 2012 procedure-code change affecting contraceptive implant insertion and removal reporting, along with a related diagnosis code crosswalk example.
-
Study These Skin Substitute Graft Additions
Covers new CPT skin substitute graft and biologic implant additions, including general guideline notes and related parenthetical references to other procedures.
-
Have Claims For a Gyn Oncologist? Implement 2 New Codes
Reviews new abdominal paracentesis codes used in a gynecologic oncology context and notes the related deleted codes and diagnosis code updates.
-
Check Out New Pathology Tests -- That You Won't Report
Summarizes several molecular pathology test families relevant to OB-Gyn care, including hereditary cancer, cystic fibrosis, clotting-related, twin zygosity, and pregnancy-related testing.
What You Will Learn
- Which broad CPT 2012 procedure updates are discussed for OB-Gyn practices
- How the article frames related diagnosis code changes in selected examples
- Which categories of skin substitute, biologic implant, and paracentesis services are highlighted
- Which molecular pathology test areas are mentioned as potentially relevant to OB-Gyn ordering patterns
Who Should Read This
- OB-Gyn coders
- OB-Gyn billing staff
- Physician practice managers
- Gynecologic oncology coding staff
- Pathology billing and coding professionals
Codes Discussed
Code Ranges Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com